NCHPC Endorsed Patient Choice Among the Recommendations for the CMS VBID Model
The National Coalition for Hospice and Palliative Care along with other leading organizations recently submitted a letter in response to the CMS request for information regarding various aspects of the Value-Based Insurance Design (VBID) Model. Among the recommendations highlighted in the letter, the coalition urged CMS to move with caution when considering network requirements and prior authorizations for the hospice carve-in of VBID. Specifically, we urged CMS not to allow Medicare Advantage (MA) organizations to limit beneficiary access to in-network providers without sufficient guardrails in place to minimize any disruptions in care – and not to move forward with hospice prior authorization at this time. As CMS moves forward with the inclusion of hospice into MA, it is imperative to consider patient choice and the importance of timely care access.
Related News
- Telehealth Flexibility for the Hospice Face-To-Face Recertification VisitSep 30, 2024Re: Telehealth Flexibility for the Hospice Face-To-Face Recertification Visit Dear Congressional Leaders: Thank you for...
- NAHC-NHPCO Alliance Announces Inaugural Chief Executive Officer: Steve Landers, MD, MPHSep 6, 2024The National Coalition for Hospice and Palliative Care (NCHPC) is pleased to welcome Steven Landers,...
- Coalition for Compassionate Care of California Joins the National Coalition for Hospice and Palliative CareAug 20, 2024The National Coalition for Hospice and Palliative Care (NCHPC) is pleased to announce the Coalition...
- Featured Event: Voices from the Field – Findings from CAPC’s First Annual Palliative Pulse SurveyAug 17, 2024CAPC’s first annual Palliative Pulse survey captured a snapshot in time of the health of...
- Resource Highlight: Concurrent CareJun 26, 2024The conversations from the convening were captured in a newly released summary report that sets the stage for next steps needed to advance concurrent care. The summary report is open access and can be used by any stakeholders with interest in advancing concurrent care.